SynthesisInternational urology and nephrology2026
The impact of protein intake on kidney adverse events in critically Ill patients: a systematic review and meta-analysis.
Synthesis in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comment on: "The impact of protein intake on kidney adverse events in critically ill patients: a systematic review and meta-analysis".International urology and nephrology · 2026Article
- Amino Acids as Metabokines in Hypercatabolic States: Rethinking Nutritional Protein-Based Strategies Beyond Caloric Support.Nutrients · 2026Review
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
Abstract
backgroundAcute kidney injury (AKI) is a common and serious complication in critically ill patients, significantly associated with increased mortality. This systematic review and meta-analysis evaluates the impact of protein intake on the incidence of renal adverse events in this population.
methodsWe included randomized controlled trials (RCTs) comparing higher (> 1.3 g/kg/day) versus lower (≤ 1.3 g/kg/day) protein intake in adult intensive care patients. PubMed, Embase, and Web of Science were searched from 1980 to April 2025. The risk of bias was assessed using the Cochrane Risk of Bias 2 (RoB2) tool. Random-effects models were used to calculate the pooled odds ratio (OR) with 95% confidence intervals(CI). The primary outcome was renal adverse events, defined as AKI or renal replacement therapy (RRT). Secondary outcomes included 28-day, intensive care unit (ICU), and hospital mortality.
resultsFourteen RCTs including 7,280 patients were analyzed. Higher protein intake was associated with a lower risk of renal adverse events (OR 0.86, 95% CI 0.76-0.98; P = 0.02; I
conclusionsProtein intake exceeding 1.3 g/kg/day is associated with a lower incidence of renal adverse events in critically ill patients, but shows no significant association with a survival advantage. These findings support tailoring protein targets to balance nutritional adequacy against renal burden. Large-scale multicenter trials are needed to establish safe and effective protein thresholds. REGISTRATION OF SYSTEMATIC REVIEWS: The protocol for this meta-analysis was prospectively registered in PROSPERO (CRD420250636693).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.